Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2010
12/23/2010WO2010108114A3 Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof
12/23/2010WO2010083495A3 Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha v beta 3 integrin
12/23/2010US20100325760 Fagopyritol synthase genes and uses thereof
12/23/2010US20100325759 Protein Kinase Stress-Related Proteins and Methods of Use in Plants
12/23/2010US20100325752 Cytokinin Oxidase Promoter from Maize
12/23/2010US20100325746 Methods and sequences to suppress primate huntington gene expression in vivo
12/23/2010US20100325744 Non-glycosylated recombinant monovalent antibodies
12/23/2010US20100324293 Monofunctionalized Perylenetetracarboxylic Acid Bismides
12/23/2010US20100324278 RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3'-end
12/23/2010US20100324277 Oligomeric compounds comprising 4'-thionucleosides for use in gene modulation
12/23/2010US20100324271 Phage-displaying single-chain antibody capable of recognizing non-reduced mannose residue
12/23/2010US20100324268 Multi-oligomeric or multi--polymeric compositions comprising labeled moieties and binding partners
12/23/2010US20100324267 Novel traf family proteins
12/23/2010US20100324266 Photocleavable Protecting Groups
12/23/2010US20100324263 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
12/23/2010US20100324262 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
12/23/2010US20100324215 Affinity structures for the specific binding of substances by means of non-covalent interaction types
12/23/2010US20100324125 Proteins derived from white spot syndrome virus and uses thereof
12/23/2010US20100324124 Compositions and methods relating to DNA-based particles
12/23/2010US20100324123 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches
12/23/2010US20100324122 Modulation of sglt2 expression
12/23/2010US20100324121 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/23/2010US20100324118 Method for the Promotion of Angiogenesis, Vascularization, or Vascular Repair or for the Inhibition of Tumor Angiogenesis
12/23/2010US20100324117 Hepatitis c dsrna effector molecules, expression constructs, compositions, and methods of use
12/23/2010US20100324116 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells
12/23/2010US20100324114 Methods and kits to detect hereditary angioedema type III
12/23/2010US20100324113 Delivery Method
12/23/2010US20100323974 Inhibitors of PARP Activity and Uses Thereof
12/23/2010US20100323971 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
12/23/2010US20100323967 RNA Antagonist Compounds for the Modulation of MCL-1
12/23/2010US20100323956 Glucose-regulating polypeptides and methods of making and using same
12/23/2010US20100323954 Chimeric polypeptides and uses thereof
12/23/2010US20100323922 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
12/23/2010US20100323908 Methods and Compositions For Diagnosing Osteoarthritis In A Feline
12/23/2010US20100323906 Nanoplasmonic molecular ruler for nuclease activity and dna footprinting
12/23/2010US20100323905 Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates
12/23/2010US20100323903 Diagnosis and prognosis of specific cancers
12/23/2010US20100323424 Targeted modification of chromatin structure
12/23/2010US20100323412 Novel gene sms 44
12/23/2010US20100323406 Mutant dna polymerases and methods of use
12/23/2010US20100323404 Method for recombining dna sequences and compositions related thereto
12/23/2010US20100323403 Polypurine tract modified retroviral vectors
12/23/2010US20100323402 Udp-glucuronyl transferase and polynucleotide encoding the same
12/23/2010US20100323399 Use of Trail Polypeptides to Treat Cancer
12/23/2010US20100323397 Modified vird2 protein and its use in improved gene transfer
12/23/2010US20100323378 Modified glucose dehydrogenase gene
12/23/2010US20100323377 Biochemical markers for cvd risk assessment
12/23/2010US20100323367 Method of detecting colon cancer marker
12/23/2010US20100323365 Primer and probe for detecting chlamydophila caviae, as well as a chlamydophila caviae detection method using the same
12/23/2010US20100323364 MODIFIED tRNA CONTAINING UNNATURAL BASE AND USE THEREOF
12/23/2010US20100323358 Use of KIR genes for predicting response to therapy
12/23/2010US20100323356 Small rna-dependent translational regulatory system in cell or artificial cell model
12/23/2010US20100323351 Tumor suppressor gene, p47ing3
12/23/2010US20100323349 Identification of the Gene and Mutation Responsible for Progressive Rod-Cone Degeneration in Dog and a Method for Testing Same
12/23/2010US20100323348 Methods and Compositions for Using Error-Detecting and/or Error-Correcting Barcodes in Nucleic Acid Amplification Process
12/23/2010US20100323346 Method of Examining Inflammatory Disease and Method of Screening Remedy for Inflammatory Disease
12/23/2010US20100323345 Methods and compositions for identifying cells by combinatorial fluorescence imaging
12/23/2010US20100323085 Fatty acid compositions having novel fatty acid rate
12/23/2010US20100323061 Enzymes for starch processing
12/23/2010US20100323024 Puumala virus full-length m segment-based dna vaccines
12/23/2010US20100323018 Branched DNA/RNA monomers and uses thereof
12/23/2010US20100323003 Flaviviridae Mutants Comprising a Deletion in the Capsid Protein for Use as Vaccines
12/23/2010US20100322977 Biomaterials, compositions, and methods
12/23/2010US20100322970 Modified influenza virus
12/23/2010US20100322955 Virulence genes, proteins, and their use
12/23/2010US20100322953 Lipidated Tumor-Associated Antigens and Immunotherapeutic Compositions
12/23/2010US20100322950 Compositions and methods for diagnosis and treatment of tumors
12/23/2010US20100322946 Multispecific antibodies
12/23/2010US20100322938 Novel clusterin derived peptide
12/23/2010US20100322937 EGF receptor epitope peptides and uses thereof
12/23/2010US20100322936 Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using same
12/23/2010US20100322932 Methods for amyloid removal using anti-amyloid antibodies
12/23/2010US20100322931 Anti-vegf antibodies and their uses
12/23/2010US20100322930 Fibronectin-based binding molecules and their use
12/23/2010US20100322919 Antibodies Against a Cancer-Associated Epitope of Variant NFKBIB and Uses Thereof
12/23/2010US20100322916 Dna repair polypeptides and methods of delivery and use
12/23/2010US20100322913 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
12/23/2010US20100322855 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
12/23/2010CA2765958A1 Improved method for quantifying dna in a biological sample
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression
12/22/2010EP2264171A1 Anti-myosine Va siRNA and skin depigmentation
12/22/2010EP2264170A1 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
12/22/2010EP2264165A2 Selection and isolation of living cells using mRNA-binding probes
12/22/2010EP2264046A1 Artificial CpG single-stranded oligodeoxynucleotide and antiviral use thereof
12/22/2010EP2264045A1 Stable compositions for nucleic acid amplification and sequencing
12/22/2010EP1027160B1 Pressure-enhanced extraction and purification
12/22/2010CN1904066B Extraction method of mammal faeces DNA
12/22/2010CN1688693B Selection and isolation of living cells using mRNA-binding probes
12/22/2010CN101921292A Novel siRNA chemical modification monomer, preparation method thereof and use thereof
12/22/2010CN101215567B Nucleic acid identification sequence and detection method for singular proteus
12/21/2010US7856320 Systems for gene expression array analysis
12/21/2010US7855323 Antisense agents; gene expression inhibition; transcription
12/21/2010US7855321 production of oils and/or triacylglycerides with an elevated content of long-chain polyunsaturated fatty acids using transgenic organisms; used in food industry, in animal nutrition, in cosmetics and in the pharmacological sector
12/21/2010US7855318 Nucleotide sequences coding cytochrome p450 variants for use as tools in identifying modulator for enhancing flavor and aroma of certain plants
12/21/2010US7855285 Methods for selective N-9 glycosylation of purines
12/21/2010US7855284 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
12/21/2010US7855283 substantially uncharged morpholino oligonucleotides having a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5'-terminal regions of the viral RNA
12/21/2010US7855282 Protein, a gene encoding therefor and a method of using the same
12/21/2010US7855281 cleaving a polynucleotide bound to a substrate via a cleavable thiocarbonate linker to produce a free polynucleotide; release polynucleotide from a solid phase synthesis
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 899